Obesity in Inflammatory Bowel Disease Is Associated with Early Readmissions Characterised by an Increased Systems and Patient-level Burden

• Published in: Journal of Crohn's and colitis Vol. 15; no. 11; pp. 1807 - 1815
• Main Authors: Weissman, Simcha, Patel, Kirtenkumar, Kolli, Sindhura, Lipcsey, Megan, Qureshi, Nabeel, Elias, Sameh, Walfish, Aaron, Swaminath, Arun, Feuerstein, Joseph D
• Format: Journal Article
• Language: English
• Published: UK Oxford University Press 08.11.2021
• Subjects: Adult; Aged; Body Mass Index; Cost of Illness; Female; Humans; Inflammatory Bowel Diseases - complications; Inflammatory Bowel Diseases - epidemiology; Male; Middle Aged; Patient Readmission - standards; Patient Readmission - statistics & numerical data; Regression Analysis; Retrospective Studies; mortality; Obesity; IBD; health care cost; readmission; outcomes
• ISSN: 1873-9946; 1876-4479
• DOI: 10.1093/ecco-jcc/jjab088

Abstract Background and Aims Rates of obesity are rising in patients with inflammatory bowel disease [IBD]. We conducted a US population-based study to determine the effects of obesity on outcomes in hospitalised patients with IBD. Methods We searched the Nationwide Readmissions Database 2016‐2017 to identify all adult patients hospitalised for IBD, using ICD-10 codes. We compared obese (body mass index [BMI] ≥ 30) vs non-obese [BMI < 30] patients with IBD to evaluate the independent effects of obesity on readmission, mortality, and other hospital outcomes. Multivariate regression and propensity matching were performed. Results We identified 143 190 patients with IBD, of whom 9.1% were obese. Obesity was independently associated with higher all-cause readmission at 30 days {18% vs 13% (adjusted odds ratio [aOR] 1.16, p = 0.005)} and 90 days (29% vs 21% [aOR 1.27, p < 0.0001]), as compared with non-obese patients, with similar findings upon a propensity-matched sensitivity analysis. Obese and non-obese patients had similar risks of mortality on index admission [0.24% vs 0.31%, p = 0.18] and readmission [1.5% vs 1.8% p = 0.3]. Obese patients had longer [5.3 vs 4.9 days] and more expensive [USD12,195 vs USD11,154] hospitalisations on index admission. Obesity did not affect the risk of intestinal surgery or bowel obstruction. Compared with index admissions, readmissions were characterised by increased mortality [6-fold], health care use, and bowel obstruction [3-fold] [all p < 0.0001]. Conclusions Obesity in IBD appears to be associated with increased early readmission, characterised by a higher burden, despite the introduction of weight-based therapeutics. Prevention of obesity should be a focus in the treatment of IBD to decrease readmission and health care burden.